These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 7928596)
21. Will compounding exist in the 21st century? Lynn RC J Am Vet Med Assoc; 1994 Jul; 205(2):296-7. PubMed ID: 7928606 [No Abstract] [Full Text] [Related]
22. Compounding in food animal practice. Dudley S J Am Vet Med Assoc; 1994 Jul; 205(2):209-12. PubMed ID: 7928578 [No Abstract] [Full Text] [Related]
23. Compounding for treatment of toxicosis. Bagley CV J Am Vet Med Assoc; 1994 Jul; 205(2):214-7. PubMed ID: 7928580 [No Abstract] [Full Text] [Related]
24. When does compounding become manufacturing? Gushee J J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585 [No Abstract] [Full Text] [Related]
25. Is compounding compatible with quality assurance programs? Lautner B J Am Vet Med Assoc; 1994 Jul; 205(2):276-9. PubMed ID: 7928597 [No Abstract] [Full Text] [Related]
26. Anticipated regulatory enforcement. Mitchell B J Am Vet Med Assoc; 1994 Jul; 205(2):299. PubMed ID: 7928608 [No Abstract] [Full Text] [Related]
27. Compliance policy guideline enforcement issues. Mitchell B J Am Vet Med Assoc; 1994 Jul; 205(2):201-2. PubMed ID: 7928574 [No Abstract] [Full Text] [Related]
28. Council stands firm on pharmaceutical compounding position. J Am Vet Med Assoc; 1992 Dec; 201(12):1821-2. PubMed ID: 1483896 [No Abstract] [Full Text] [Related]
29. Are AVMA guidelines too restrictive? Mandelker L J Am Vet Med Assoc; 1994 Jul; 205(2):238-40. PubMed ID: 7928587 [No Abstract] [Full Text] [Related]
30. Medical Device; exemption from premarket notification; class II devices; pharmacy compounding systems. Final rule. Food and Drug Administration, HHS Fed Regist; 2001 Mar; 66(55):15796-8. PubMed ID: 11706859 [TBL] [Abstract][Full Text] [Related]
31. Educating veterinarians to prescribe and use drugs in a responsible manner. Jenkins WL J Am Vet Med Assoc; 1993 May; 202(10):1708-10;discussion 1713-7. PubMed ID: 8514590 [No Abstract] [Full Text] [Related]
32. Implications for the FDA/Center for Veterinary Medicine (CVM). Geyer RE J Am Vet Med Assoc; 1993 May; 202(10):1718-23. PubMed ID: 8514592 [No Abstract] [Full Text] [Related]
33. Extemporaneous compounding in veterinary practice: a New Zealand perspective. Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952 [TBL] [Abstract][Full Text] [Related]
34. Rationale for compounding commercially available products. Murry T Am J Vet Res; 2009 Nov; 70(11):1307; author reply 1307-8. PubMed ID: 19878010 [No Abstract] [Full Text] [Related]
35. Drug use guidelines for veterinary practitioners. Gloyd JS J Am Vet Med Assoc; 1993 May; 202(10):1738-9;discussion 1740-1. PubMed ID: 8514600 [No Abstract] [Full Text] [Related]
36. Pharmacist compounding vs veterinarian compounding: similarities and differences. Jordan DG J Am Vet Med Assoc; 1994 Jul; 205(2):256-60. PubMed ID: 7928593 [No Abstract] [Full Text] [Related]
37. Contemporary pharmaceutical compounding. Allen LV Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042 [No Abstract] [Full Text] [Related]
38. Extralabel drug use and compounding in veterinary medicine. Geyer RE Food Drug Law J; 1997; 52(3):291-5. PubMed ID: 10343027 [No Abstract] [Full Text] [Related]
39. Some compounding may be allowed, even if still illegal. J Am Vet Med Assoc; 2015 Jul; 247(1):25. PubMed ID: 26285314 [No Abstract] [Full Text] [Related]
40. The compounding controversy: what veterinarians should know to protect themselves and their patients. Davidson G J Am Anim Hosp Assoc; 2003; 39(1):13-7. PubMed ID: 12549608 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]